Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer

• A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer
• Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Prospective project in collecting and assessing clinical outcomes data related to molecular profiling of tumors based on cancer primary or metastatic tissue or tissue from peripheral blood samples. As a future part of the project will be collected patient reported outcomes (PROs) for assessing clinical outcomes in relation to clinical pathways, patient reported results, as well as tumor profiling by molecular methods.

Inclusion Criteria:

• Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery
• Informed consent to participate
• Age ≥18

Exclusion Criteria:

• failure to provide written informed consent